Predictmedix AI, Inc. is a life sciences technology company, which engages in developing artificial intelligence (AI) powered technologies for general workplace health and safety, and for the health care industry. The company is headquartered in Toronto, Ontario. The company went IPO on 2019-12-20. The Company, through its subsidiaries, focuses on artificial intelligence (AI) technologies which target two specific areas: workplace health and safety and healthcare. The company has developed a technology for the identification and detection of infectious disease symptoms, including COVID-19, referred to as its infectious disease symptom screening solutions (IDSS) and marketed in North America under the name Safe Entry System. The company is also developing AI-powered products that address the detection of alcohol and/or cannabis impairment in individuals; mental illness screening, and remote patient monitoring and treatment plans, referred to as the Mobile Wellbeing product. The company is adding additional modules to this Mobile Wellbeing platform that help to use a patient’s history and real-time medical data, such as blood pressure, and to provide patients and their medical professionals with treatment plans for chronic disease management.
Follow-Up Questions
Who is the CEO of Predictmedix AI Inc?
Mr. Sheldon Kales is the President of Predictmedix AI Inc, joining the firm since 2019.
What is the price performance of PMEDF stock?
The current price of PMEDF is $0.0283, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Predictmedix AI Inc?
Predictmedix AI Inc belongs to N/A industry and the sector is N/A
